Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Uveal Neoplasms | 24 | 2024 | 341 | 5.990 |
Why?
|
Macular Degeneration | 39 | 2023 | 1007 | 4.390 |
Why?
|
Choroid Neoplasms | 10 | 2023 | 177 | 3.860 |
Why?
|
Melanoma | 34 | 2024 | 5709 | 3.240 |
Why?
|
Choroidal Neovascularization | 17 | 2021 | 363 | 2.410 |
Why?
|
Visual Acuity | 33 | 2024 | 2672 | 1.940 |
Why?
|
Wet Macular Degeneration | 8 | 2023 | 162 | 1.230 |
Why?
|
Choroid | 9 | 2023 | 360 | 1.030 |
Why?
|
Angiogenesis Inhibitors | 12 | 2023 | 2047 | 1.000 |
Why?
|
Vision Disorders | 5 | 2019 | 1088 | 0.960 |
Why?
|
Zinc Compounds | 2 | 2014 | 36 | 0.910 |
Why?
|
Radiation Injuries | 4 | 2018 | 1189 | 0.890 |
Why?
|
Polymorphism, Single Nucleotide | 16 | 2018 | 15936 | 0.880 |
Why?
|
Dark Adaptation | 7 | 2021 | 222 | 0.850 |
Why?
|
Intravitreal Injections | 7 | 2020 | 385 | 0.800 |
Why?
|
Choroid Diseases | 2 | 2019 | 63 | 0.780 |
Why?
|
Tomography, Optical Coherence | 20 | 2021 | 2917 | 0.770 |
Why?
|
Complement Factor H | 9 | 2013 | 110 | 0.750 |
Why?
|
Vascular Endothelial Growth Factor A | 14 | 2023 | 3492 | 0.730 |
Why?
|
Photochemotherapy | 7 | 2021 | 823 | 0.710 |
Why?
|
Fluorescein Angiography | 18 | 2021 | 1059 | 0.700 |
Why?
|
Protons | 6 | 2022 | 1116 | 0.680 |
Why?
|
Serine Endopeptidases | 6 | 2013 | 1022 | 0.660 |
Why?
|
Retinal Diseases | 4 | 2022 | 705 | 0.590 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2024 | 9280 | 0.580 |
Why?
|
Eye Neoplasms | 4 | 2022 | 307 | 0.580 |
Why?
|
Fovea Centralis | 2 | 2015 | 126 | 0.570 |
Why?
|
Vitrectomy | 7 | 2019 | 392 | 0.570 |
Why?
|
Ubiquitin Thiolesterase | 3 | 2015 | 455 | 0.570 |
Why?
|
Granuloma | 1 | 2019 | 328 | 0.560 |
Why?
|
Endophthalmitis | 3 | 2020 | 260 | 0.540 |
Why?
|
Eye Injuries | 3 | 2016 | 227 | 0.520 |
Why?
|
Optic Disk | 3 | 2011 | 421 | 0.520 |
Why?
|
Proteins | 6 | 2014 | 6032 | 0.510 |
Why?
|
Antioxidants | 2 | 2014 | 1668 | 0.510 |
Why?
|
Radiotherapy, High-Energy | 3 | 2010 | 228 | 0.500 |
Why?
|
Posterior Capsule of the Lens | 1 | 2015 | 2 | 0.500 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 3 | 2020 | 664 | 0.460 |
Why?
|
Anterior Chamber | 1 | 2015 | 194 | 0.460 |
Why?
|
Optic Nerve Neoplasms | 3 | 2011 | 45 | 0.430 |
Why?
|
Porphyrins | 4 | 2011 | 352 | 0.420 |
Why?
|
Retina | 9 | 2023 | 2659 | 0.420 |
Why?
|
Lens, Crystalline | 1 | 2015 | 389 | 0.410 |
Why?
|
Aged, 80 and over | 39 | 2024 | 58976 | 0.410 |
Why?
|
Skin Neoplasms | 6 | 2023 | 5821 | 0.400 |
Why?
|
Tumor Suppressor Proteins | 4 | 2015 | 2803 | 0.400 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2012 | 102 | 0.390 |
Why?
|
Laser Coagulation | 3 | 2011 | 330 | 0.390 |
Why?
|
Pseudophakia | 1 | 2012 | 60 | 0.390 |
Why?
|
Hemangioma | 2 | 2022 | 727 | 0.380 |
Why?
|
Retinal Perforations | 3 | 2019 | 138 | 0.380 |
Why?
|
Bruch Membrane | 4 | 2014 | 65 | 0.370 |
Why?
|
Nevus, Pigmented | 3 | 2010 | 222 | 0.360 |
Why?
|
Amino Acid Oxidoreductases | 2 | 2008 | 149 | 0.360 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 506 | 0.360 |
Why?
|
Angioid Streaks | 1 | 2010 | 14 | 0.360 |
Why?
|
Myopia, Degenerative | 1 | 2010 | 15 | 0.360 |
Why?
|
Lens Implantation, Intraocular | 2 | 2012 | 191 | 0.360 |
Why?
|
Aged | 61 | 2024 | 169289 | 0.360 |
Why?
|
Drug Substitution | 1 | 2013 | 290 | 0.350 |
Why?
|
Photosensitizing Agents | 5 | 2021 | 623 | 0.350 |
Why?
|
Retinal Drusen | 4 | 2021 | 74 | 0.350 |
Why?
|
Retrospective Studies | 32 | 2024 | 80636 | 0.350 |
Why?
|
Histoplasmosis | 1 | 2010 | 63 | 0.350 |
Why?
|
Eye Infections, Bacterial | 1 | 2013 | 242 | 0.340 |
Why?
|
Metabolomics | 5 | 2023 | 1659 | 0.340 |
Why?
|
Germ-Line Mutation | 2 | 2015 | 1858 | 0.330 |
Why?
|
Retinal Vessels | 3 | 2017 | 852 | 0.320 |
Why?
|
Recombinant Fusion Proteins | 3 | 2020 | 3734 | 0.320 |
Why?
|
Middle Aged | 62 | 2024 | 220895 | 0.320 |
Why?
|
Male | 80 | 2024 | 360804 | 0.320 |
Why?
|
Humans | 111 | 2024 | 761504 | 0.310 |
Why?
|
Cataract | 1 | 2015 | 832 | 0.310 |
Why?
|
Forecasting | 1 | 2017 | 2928 | 0.310 |
Why?
|
Female | 75 | 2024 | 392644 | 0.310 |
Why?
|
Geographic Atrophy | 3 | 2019 | 91 | 0.300 |
Why?
|
Cataract Extraction | 2 | 2012 | 467 | 0.300 |
Why?
|
Elastic Tissue | 1 | 2008 | 66 | 0.300 |
Why?
|
Follow-Up Studies | 18 | 2024 | 39106 | 0.300 |
Why?
|
Macular Edema | 1 | 2012 | 374 | 0.290 |
Why?
|
Retinal Pigment Epithelium | 4 | 2021 | 303 | 0.280 |
Why?
|
Retinal Detachment | 5 | 2016 | 428 | 0.280 |
Why?
|
Optic Nerve Diseases | 1 | 2010 | 342 | 0.270 |
Why?
|
Phosphenes | 1 | 2006 | 41 | 0.260 |
Why?
|
Chromosomes, Human, Pair 10 | 4 | 2011 | 277 | 0.260 |
Why?
|
Diagnostic Techniques, Ophthalmological | 4 | 2018 | 251 | 0.260 |
Why?
|
Radiotherapy Dosage | 6 | 2022 | 2898 | 0.250 |
Why?
|
Glaucoma | 1 | 2015 | 1185 | 0.240 |
Why?
|
Vitreous Body | 4 | 2019 | 399 | 0.240 |
Why?
|
Alleles | 6 | 2023 | 6863 | 0.240 |
Why?
|
Antibodies, Monoclonal | 4 | 2010 | 9177 | 0.230 |
Why?
|
Serine-Type D-Ala-D-Ala Carboxypeptidase | 1 | 2023 | 16 | 0.230 |
Why?
|
Adult | 38 | 2024 | 221177 | 0.230 |
Why?
|
Monosomy | 1 | 2024 | 52 | 0.230 |
Why?
|
Survival Rate | 8 | 2024 | 12725 | 0.230 |
Why?
|
Sound | 1 | 2006 | 257 | 0.230 |
Why?
|
Hallucinations | 1 | 2006 | 366 | 0.210 |
Why?
|
Genotype | 12 | 2018 | 12990 | 0.210 |
Why?
|
Lens Subluxation | 1 | 2002 | 23 | 0.210 |
Why?
|
Aptamers, Nucleotide | 2 | 2014 | 165 | 0.200 |
Why?
|
Usher Syndromes | 1 | 2023 | 56 | 0.200 |
Why?
|
Risk Factors | 19 | 2024 | 74206 | 0.200 |
Why?
|
Phacoemulsification | 2 | 2010 | 149 | 0.200 |
Why?
|
Environment | 1 | 2008 | 1123 | 0.200 |
Why?
|
DNA, Neoplasm | 2 | 2021 | 1745 | 0.200 |
Why?
|
Diabetic Retinopathy | 3 | 2018 | 1274 | 0.190 |
Why?
|
Iris | 2 | 2020 | 232 | 0.190 |
Why?
|
Visual Field Tests | 2 | 2019 | 411 | 0.190 |
Why?
|
Sturge-Weber Syndrome | 1 | 2022 | 89 | 0.190 |
Why?
|
Complement C3 | 2 | 2013 | 435 | 0.190 |
Why?
|
Vitreoretinopathy, Proliferative | 1 | 2002 | 76 | 0.190 |
Why?
|
Cause of Death | 5 | 2016 | 3683 | 0.190 |
Why?
|
Glaucoma, Neovascular | 1 | 2020 | 37 | 0.180 |
Why?
|
Drug Therapy, Combination | 5 | 2014 | 6310 | 0.180 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 1 | 2 | 2011 | 49 | 0.180 |
Why?
|
Retinal Vasculitis | 1 | 2020 | 46 | 0.180 |
Why?
|
Genetic Testing | 1 | 2013 | 3537 | 0.180 |
Why?
|
Conjunctival Neoplasms | 1 | 2021 | 77 | 0.180 |
Why?
|
Retinal Artery Occlusion | 1 | 2020 | 77 | 0.170 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2021 | 2872 | 0.170 |
Why?
|
Gene Expression Profiling | 5 | 2024 | 9420 | 0.170 |
Why?
|
Retinal Rod Photoreceptor Cells | 1 | 2021 | 204 | 0.170 |
Why?
|
Combined Modality Therapy | 5 | 2016 | 8529 | 0.170 |
Why?
|
Retinal Neovascularization | 2 | 2014 | 288 | 0.170 |
Why?
|
Hamartoma | 1 | 2022 | 235 | 0.170 |
Why?
|
Liver Neoplasms | 2 | 2018 | 4320 | 0.170 |
Why?
|
Subretinal Fluid | 1 | 2019 | 24 | 0.170 |
Why?
|
Iris Neoplasms | 1 | 2019 | 13 | 0.160 |
Why?
|
Endotamponade | 1 | 2019 | 37 | 0.160 |
Why?
|
Ciliary Arteries | 1 | 2019 | 19 | 0.160 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 2 | 2014 | 558 | 0.160 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2020 | 190 | 0.160 |
Why?
|
Prospective Studies | 19 | 2024 | 54425 | 0.160 |
Why?
|
Retinal Telangiectasis | 1 | 2019 | 25 | 0.160 |
Why?
|
Remission, Spontaneous | 1 | 2019 | 384 | 0.160 |
Why?
|
Epiretinal Membrane | 1 | 2019 | 73 | 0.160 |
Why?
|
Ciliary Body | 2 | 2020 | 167 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 11 | 2017 | 17904 | 0.150 |
Why?
|
Homocysteine | 1 | 2021 | 638 | 0.150 |
Why?
|
Polymerase Chain Reaction | 6 | 2016 | 6075 | 0.150 |
Why?
|
Melphalan | 1 | 2019 | 420 | 0.150 |
Why?
|
Eye Enucleation | 4 | 2014 | 128 | 0.150 |
Why?
|
Treatment Outcome | 12 | 2024 | 64680 | 0.150 |
Why?
|
Light Coagulation | 2 | 2014 | 72 | 0.140 |
Why?
|
Young Adult | 14 | 2024 | 59243 | 0.140 |
Why?
|
Body Fluids | 1 | 2019 | 320 | 0.140 |
Why?
|
Pilot Projects | 2 | 2024 | 8631 | 0.140 |
Why?
|
Intraoperative Complications | 2 | 2010 | 1165 | 0.140 |
Why?
|
Foscarnet | 1 | 2016 | 35 | 0.140 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2020 | 540 | 0.140 |
Why?
|
Retinal Necrosis Syndrome, Acute | 1 | 2016 | 24 | 0.140 |
Why?
|
C-Reactive Protein | 1 | 2008 | 3826 | 0.140 |
Why?
|
Herpes Zoster Ophthalmicus | 1 | 2016 | 37 | 0.130 |
Why?
|
Antigens, Neoplasm | 1 | 2024 | 1993 | 0.130 |
Why?
|
Ocular Hypertension | 1 | 2018 | 209 | 0.130 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2021 | 894 | 0.130 |
Why?
|
Eye Infections, Viral | 1 | 2016 | 60 | 0.130 |
Why?
|
Scleral Buckling | 1 | 2016 | 95 | 0.130 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2019 | 617 | 0.130 |
Why?
|
Retinal Hemorrhage | 1 | 2016 | 95 | 0.130 |
Why?
|
Cytosine | 1 | 2016 | 211 | 0.120 |
Why?
|
Microscopy, Acoustic | 1 | 2015 | 47 | 0.120 |
Why?
|
Photoreceptor Cells | 2 | 2023 | 236 | 0.120 |
Why?
|
Brachytherapy | 1 | 2022 | 1223 | 0.120 |
Why?
|
Polyps | 1 | 2016 | 200 | 0.120 |
Why?
|
Biopsy, Fine-Needle | 1 | 2019 | 1118 | 0.110 |
Why?
|
Relative Biological Effectiveness | 1 | 2015 | 312 | 0.110 |
Why?
|
Cross-Sectional Studies | 13 | 2021 | 26125 | 0.110 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2024 | 3639 | 0.110 |
Why?
|
Genome-Wide Association Study | 5 | 2023 | 12690 | 0.110 |
Why?
|
Neuroectodermal Tumors, Primitive | 1 | 2014 | 136 | 0.110 |
Why?
|
Fundus Oculi | 4 | 2020 | 556 | 0.110 |
Why?
|
Prognosis | 9 | 2024 | 29625 | 0.110 |
Why?
|
Complement Pathway, Alternative | 1 | 2013 | 113 | 0.110 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2449 | 0.110 |
Why?
|
Cytogenetics | 1 | 2013 | 198 | 0.110 |
Why?
|
Herpes Simplex | 1 | 2016 | 478 | 0.110 |
Why?
|
Gene Frequency | 5 | 2013 | 3606 | 0.100 |
Why?
|
Adolescent | 14 | 2021 | 88319 | 0.100 |
Why?
|
Pharmacogenetics | 2 | 2013 | 675 | 0.100 |
Why?
|
Triamcinolone Acetonide | 1 | 2013 | 100 | 0.100 |
Why?
|
Polymorphism, Genetic | 2 | 2014 | 4243 | 0.100 |
Why?
|
Protein Biosynthesis | 2 | 2017 | 2113 | 0.100 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2022 | 2057 | 0.100 |
Why?
|
Linkage Disequilibrium | 4 | 2013 | 1998 | 0.100 |
Why?
|
beta Carotene | 1 | 2013 | 523 | 0.100 |
Why?
|
Visual Fields | 1 | 2019 | 1062 | 0.100 |
Why?
|
Postoperative Complications | 3 | 2013 | 15631 | 0.100 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2012 | 147 | 0.100 |
Why?
|
Mutation | 5 | 2017 | 30052 | 0.100 |
Why?
|
Lymphocytes | 1 | 2019 | 2612 | 0.090 |
Why?
|
Phenotype | 4 | 2015 | 16591 | 0.090 |
Why?
|
Integrin alphaVbeta3 | 1 | 2011 | 105 | 0.090 |
Why?
|
Skull Base Neoplasms | 1 | 2014 | 270 | 0.090 |
Why?
|
Case-Control Studies | 10 | 2019 | 22176 | 0.090 |
Why?
|
Tissue Inhibitor of Metalloproteinase-3 | 1 | 2010 | 34 | 0.090 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 2898 | 0.090 |
Why?
|
Macaca fascicularis | 3 | 2010 | 903 | 0.090 |
Why?
|
Ascorbic Acid | 1 | 2013 | 655 | 0.090 |
Why?
|
Retreatment | 1 | 2011 | 598 | 0.090 |
Why?
|
Lipids | 2 | 2018 | 3341 | 0.080 |
Why?
|
Capillary Permeability | 3 | 2008 | 773 | 0.080 |
Why?
|
Retinal Neoplasms | 1 | 2011 | 146 | 0.080 |
Why?
|
Genetic Variation | 4 | 2014 | 6567 | 0.080 |
Why?
|
Photography | 2 | 2018 | 532 | 0.080 |
Why?
|
Vitamin E | 1 | 2013 | 872 | 0.080 |
Why?
|
Microfilament Proteins | 1 | 2014 | 1134 | 0.080 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2011 | 638 | 0.080 |
Why?
|
Antigens, CD | 1 | 2019 | 4003 | 0.080 |
Why?
|
Torsion Abnormality | 1 | 2009 | 91 | 0.080 |
Why?
|
Intraocular Pressure | 1 | 2015 | 1294 | 0.080 |
Why?
|
Liver Function Tests | 1 | 2010 | 523 | 0.080 |
Why?
|
Incidence | 4 | 2020 | 21353 | 0.080 |
Why?
|
Membrane Proteins | 4 | 2011 | 7856 | 0.080 |
Why?
|
Retinal Artery | 1 | 2009 | 109 | 0.080 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2014 | 3810 | 0.080 |
Why?
|
Neoplasms, Second Primary | 1 | 2016 | 1052 | 0.070 |
Why?
|
Registries | 1 | 2024 | 8224 | 0.070 |
Why?
|
Gene Amplification | 1 | 2012 | 1089 | 0.070 |
Why?
|
Microscopy, Immunoelectron | 1 | 2008 | 317 | 0.070 |
Why?
|
Blood-Retinal Barrier | 1 | 2008 | 62 | 0.070 |
Why?
|
Haplotypes | 3 | 2008 | 2713 | 0.070 |
Why?
|
Systems Biology | 1 | 2011 | 481 | 0.070 |
Why?
|
Glucocorticoids | 2 | 2008 | 2161 | 0.070 |
Why?
|
Genetic Association Studies | 2 | 2014 | 2735 | 0.070 |
Why?
|
Histidine | 1 | 2008 | 308 | 0.070 |
Why?
|
Neoplasm Staging | 4 | 2021 | 11121 | 0.070 |
Why?
|
DNA Mutational Analysis | 2 | 2014 | 4111 | 0.070 |
Why?
|
Collagen Type XVIII | 1 | 2007 | 52 | 0.070 |
Why?
|
Cytoskeletal Proteins | 2 | 2023 | 1342 | 0.070 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2008 | 427 | 0.070 |
Why?
|
Genetic Markers | 1 | 2013 | 2601 | 0.070 |
Why?
|
Exfoliation Syndrome | 1 | 2008 | 113 | 0.070 |
Why?
|
Endostatins | 1 | 2007 | 168 | 0.070 |
Why?
|
Oncogenes | 1 | 2012 | 1222 | 0.070 |
Why?
|
Immunotherapy | 2 | 2019 | 4652 | 0.070 |
Why?
|
Eye Abnormalities | 1 | 2009 | 242 | 0.070 |
Why?
|
Elastin | 1 | 2008 | 298 | 0.070 |
Why?
|
RNA | 2 | 2014 | 2726 | 0.070 |
Why?
|
Sequence Analysis, DNA | 2 | 2015 | 4740 | 0.070 |
Why?
|
Carotid Artery, Internal | 1 | 2009 | 445 | 0.070 |
Why?
|
3' Untranslated Regions | 1 | 2008 | 519 | 0.070 |
Why?
|
Injections | 2 | 2006 | 830 | 0.060 |
Why?
|
Aneurysm | 1 | 2009 | 337 | 0.060 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2008 | 353 | 0.060 |
Why?
|
Suture Techniques | 1 | 2010 | 769 | 0.060 |
Why?
|
Fusarium | 1 | 2005 | 51 | 0.060 |
Why?
|
Lipoproteins, HDL | 1 | 2010 | 676 | 0.060 |
Why?
|
Microsatellite Repeats | 1 | 2007 | 784 | 0.060 |
Why?
|
Dependovirus | 1 | 2010 | 718 | 0.060 |
Why?
|
Matrix Metalloproteinases | 1 | 2008 | 393 | 0.060 |
Why?
|
Nerve Tissue Proteins | 2 | 2023 | 4414 | 0.060 |
Why?
|
Receptors, Immunologic | 1 | 2011 | 1410 | 0.060 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2013 | 1934 | 0.060 |
Why?
|
Microsurgery | 1 | 2010 | 795 | 0.060 |
Why?
|
Vitamins | 1 | 2013 | 1635 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8547 | 0.060 |
Why?
|
Mice, Inbred C57BL | 6 | 2021 | 22169 | 0.060 |
Why?
|
Immunoblotting | 1 | 2008 | 1646 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9326 | 0.060 |
Why?
|
Sensory Thresholds | 2 | 2017 | 377 | 0.060 |
Why?
|
Aspergillus fumigatus | 1 | 2005 | 157 | 0.060 |
Why?
|
Genome, Human | 1 | 2017 | 4425 | 0.060 |
Why?
|
Genetic Linkage | 1 | 2009 | 2341 | 0.060 |
Why?
|
Tyrosine | 1 | 2008 | 1440 | 0.060 |
Why?
|
Antiviral Agents | 1 | 2016 | 3060 | 0.060 |
Why?
|
Disease Progression | 3 | 2020 | 13506 | 0.060 |
Why?
|
Genetic Loci | 1 | 2013 | 2632 | 0.050 |
Why?
|
Demography | 1 | 2008 | 1648 | 0.050 |
Why?
|
Peptides, Cyclic | 1 | 2005 | 392 | 0.050 |
Why?
|
Eye Proteins | 1 | 2007 | 633 | 0.050 |
Why?
|
Chromosome Mapping | 2 | 2010 | 4615 | 0.050 |
Why?
|
Disease Models, Animal | 5 | 2021 | 18252 | 0.050 |
Why?
|
Phosphate-Binding Proteins | 1 | 2023 | 93 | 0.050 |
Why?
|
Confidence Intervals | 3 | 2015 | 2927 | 0.050 |
Why?
|
Carrier Proteins | 2 | 2023 | 4936 | 0.050 |
Why?
|
Smoking | 3 | 2011 | 9053 | 0.050 |
Why?
|
Blood Proteins | 1 | 2008 | 1173 | 0.050 |
Why?
|
Carotid Artery Diseases | 1 | 2009 | 877 | 0.050 |
Why?
|
Chronic Disease | 2 | 2018 | 9318 | 0.050 |
Why?
|
Exons | 1 | 2008 | 2391 | 0.050 |
Why?
|
Academic Medical Centers | 1 | 2013 | 2759 | 0.050 |
Why?
|
Microscopy, Electron | 1 | 2006 | 2561 | 0.050 |
Why?
|
Greece | 2 | 2014 | 340 | 0.050 |
Why?
|
Regression Analysis | 2 | 2010 | 6343 | 0.050 |
Why?
|
Massachusetts | 2 | 2013 | 8830 | 0.050 |
Why?
|
Mycoses | 1 | 2005 | 386 | 0.050 |
Why?
|
Acute Disease | 1 | 2013 | 7237 | 0.050 |
Why?
|
Cystathionine beta-Synthase | 1 | 2021 | 27 | 0.050 |
Why?
|
Vitamin D Deficiency | 1 | 2011 | 1388 | 0.050 |
Why?
|
Protein Stability | 2 | 2014 | 578 | 0.050 |
Why?
|
Mice, Knockout | 3 | 2021 | 14414 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 3 | 2018 | 6484 | 0.050 |
Why?
|
Acoustic Stimulation | 1 | 2006 | 1235 | 0.050 |
Why?
|
Neoplasm Metastasis | 1 | 2012 | 4915 | 0.050 |
Why?
|
Transcription Factors | 1 | 2021 | 12128 | 0.050 |
Why?
|
Databases, Genetic | 1 | 2008 | 1742 | 0.050 |
Why?
|
Glaucoma, Open-Angle | 1 | 2008 | 738 | 0.050 |
Why?
|
Apolipoproteins E | 1 | 2007 | 1444 | 0.050 |
Why?
|
Anti-Bacterial Agents | 2 | 2013 | 7407 | 0.050 |
Why?
|
Hyperhomocysteinemia | 1 | 2021 | 118 | 0.050 |
Why?
|
Genetic Vectors | 1 | 2010 | 3395 | 0.050 |
Why?
|
Extracellular Matrix | 2 | 2014 | 1726 | 0.050 |
Why?
|
Recurrence | 1 | 2013 | 8465 | 0.040 |
Why?
|
Dexamethasone | 1 | 2008 | 1948 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2013 | 3415 | 0.040 |
Why?
|
Antifungal Agents | 1 | 2005 | 752 | 0.040 |
Why?
|
Diagnosis, Differential | 4 | 2022 | 12974 | 0.040 |
Why?
|
Portugal | 1 | 2020 | 91 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2024 | 6814 | 0.040 |
Why?
|
Triazoles | 1 | 2005 | 903 | 0.040 |
Why?
|
Longitudinal Studies | 2 | 2021 | 14605 | 0.040 |
Why?
|
GTP-Binding Proteins | 1 | 2023 | 951 | 0.040 |
Why?
|
Animals | 12 | 2021 | 168459 | 0.040 |
Why?
|
Child | 7 | 2022 | 80153 | 0.040 |
Why?
|
In Situ Nick-End Labeling | 2 | 2011 | 613 | 0.040 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2020 | 224 | 0.040 |
Why?
|
Meta-Analysis as Topic | 2 | 2014 | 1380 | 0.040 |
Why?
|
Rats, Inbred BN | 2 | 2008 | 231 | 0.040 |
Why?
|
Ultrasonography | 2 | 2014 | 5972 | 0.040 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2019 | 3769 | 0.040 |
Why?
|
Inflammasomes | 1 | 2023 | 526 | 0.040 |
Why?
|
Eye | 2 | 2012 | 712 | 0.040 |
Why?
|
Vitamin D | 1 | 2011 | 3303 | 0.040 |
Why?
|
Eukaryotic Initiation Factor-1 | 1 | 2017 | 31 | 0.040 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 619 | 0.040 |
Why?
|
Mice | 7 | 2021 | 81525 | 0.040 |
Why?
|
Area Under Curve | 1 | 2021 | 1638 | 0.040 |
Why?
|
Interleukin-1beta | 1 | 2023 | 999 | 0.040 |
Why?
|
Indocyanine Green | 1 | 2019 | 233 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2008 | 5789 | 0.030 |
Why?
|
United States | 7 | 2020 | 72334 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2024 | 2020 | 0.030 |
Why?
|
Coloring Agents | 1 | 2019 | 562 | 0.030 |
Why?
|
Metabolome | 1 | 2023 | 989 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2024 | 16981 | 0.030 |
Why?
|
Exudates and Transudates | 1 | 2016 | 174 | 0.030 |
Why?
|
Herpesvirus 3, Human | 1 | 2016 | 159 | 0.030 |
Why?
|
Pedigree | 2 | 2014 | 4542 | 0.030 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2018 | 354 | 0.030 |
Why?
|
Siblings | 2 | 2011 | 825 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2330 | 0.030 |
Why?
|
Gene Expression | 2 | 2023 | 7581 | 0.030 |
Why?
|
Sirolimus | 1 | 2022 | 1533 | 0.030 |
Why?
|
Endothelial Cells | 2 | 2021 | 3548 | 0.030 |
Why?
|
Haiti | 1 | 2016 | 550 | 0.030 |
Why?
|
Europe | 1 | 2020 | 3422 | 0.030 |
Why?
|
Time | 1 | 2015 | 546 | 0.030 |
Why?
|
Receptors, Somatomedin | 1 | 2013 | 56 | 0.030 |
Why?
|
Pyrimidines | 1 | 2005 | 3028 | 0.030 |
Why?
|
Cohort Studies | 5 | 2017 | 41487 | 0.030 |
Why?
|
Simplexvirus | 1 | 2016 | 803 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2019 | 1971 | 0.030 |
Why?
|
Time Factors | 3 | 2020 | 39967 | 0.030 |
Why?
|
Rats | 4 | 2011 | 23742 | 0.030 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2014 | 882 | 0.030 |
Why?
|
Trypsin | 1 | 2013 | 495 | 0.030 |
Why?
|
Alcohol Drinking | 2 | 2018 | 4028 | 0.030 |
Why?
|
Survival Analysis | 2 | 2015 | 10090 | 0.020 |
Why?
|
Energy Intake | 1 | 2020 | 2134 | 0.020 |
Why?
|
Republic of Korea | 1 | 2014 | 590 | 0.020 |
Why?
|
Dietary Fats | 1 | 2020 | 1995 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2014 | 878 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2016 | 2219 | 0.020 |
Why?
|
Radiotherapy | 1 | 2018 | 1499 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2014 | 1705 | 0.020 |
Why?
|
Lasers, Semiconductor | 1 | 2011 | 41 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2023 | 3448 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2021 | 2645 | 0.020 |
Why?
|
SEER Program | 1 | 2016 | 1450 | 0.020 |
Why?
|
Rhodamines | 1 | 2011 | 178 | 0.020 |
Why?
|
Wound Healing | 1 | 2002 | 2805 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2013 | 452 | 0.020 |
Why?
|
Complement Factor I | 1 | 2010 | 14 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2192 | 0.020 |
Why?
|
Sex Distribution | 1 | 2015 | 2281 | 0.020 |
Why?
|
Databases, Factual | 2 | 2016 | 7967 | 0.020 |
Why?
|
Apoptosis | 3 | 2011 | 9486 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2014 | 2180 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2010 | 20570 | 0.020 |
Why?
|
Age Distribution | 1 | 2015 | 2880 | 0.020 |
Why?
|
Epistasis, Genetic | 1 | 2011 | 352 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2014 | 1834 | 0.020 |
Why?
|
Odds Ratio | 2 | 2015 | 9646 | 0.020 |
Why?
|
Receptors, Calcitriol | 1 | 2011 | 360 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2011 | 855 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 3 | 2019 | 36426 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2011 | 852 | 0.020 |
Why?
|
Monocyte Chemoattractant Proteins | 1 | 2008 | 47 | 0.020 |
Why?
|
Evans Blue | 1 | 2008 | 42 | 0.020 |
Why?
|
Homozygote | 1 | 2013 | 1776 | 0.020 |
Why?
|
Epidemiologic Studies | 1 | 2011 | 675 | 0.020 |
Why?
|
Aprotinin | 1 | 2008 | 94 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2008 | 413 | 0.020 |
Why?
|
Pichia | 1 | 2007 | 49 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15601 | 0.020 |
Why?
|
Body Mass Index | 2 | 2018 | 12953 | 0.020 |
Why?
|
Rats, Long-Evans | 1 | 2008 | 383 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3595 | 0.020 |
Why?
|
Fluoresceins | 1 | 2007 | 235 | 0.020 |
Why?
|
Receptors, CCR2 | 1 | 2008 | 215 | 0.020 |
Why?
|
Infant | 2 | 2022 | 36192 | 0.020 |
Why?
|
Conjunctiva | 1 | 2010 | 479 | 0.020 |
Why?
|
Cytokines | 1 | 2002 | 7396 | 0.020 |
Why?
|
Lasers | 1 | 2011 | 952 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2010 | 1900 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2009 | 749 | 0.020 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2008 | 175 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2020 | 12341 | 0.020 |
Why?
|
Life Style | 1 | 2018 | 3917 | 0.020 |
Why?
|
Protein Conformation | 1 | 2014 | 3968 | 0.020 |
Why?
|
Plasmids | 1 | 2011 | 2269 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2011 | 2065 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2008 | 605 | 0.020 |
Why?
|
Echinocandins | 1 | 2005 | 53 | 0.020 |
Why?
|
Lipopeptides | 1 | 2005 | 71 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2011 | 15500 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2021 | 10445 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2008 | 695 | 0.020 |
Why?
|
Molecular Epidemiology | 1 | 2007 | 469 | 0.010 |
Why?
|
Eye Infections, Fungal | 1 | 2005 | 100 | 0.010 |
Why?
|
Hypercholesterolemia | 1 | 2011 | 1141 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2011 | 2707 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4063 | 0.010 |
Why?
|
Models, Molecular | 1 | 2014 | 5439 | 0.010 |
Why?
|
Angiography | 1 | 2009 | 1595 | 0.010 |
Why?
|
Comorbidity | 1 | 2018 | 10508 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13255 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 13446 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3617 | 0.010 |
Why?
|
Patient Selection | 1 | 2014 | 4244 | 0.010 |
Why?
|
Diet | 1 | 2020 | 8075 | 0.010 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2008 | 1119 | 0.010 |
Why?
|
Risk Assessment | 2 | 2015 | 23995 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17635 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12463 | 0.010 |
Why?
|
Protein Binding | 1 | 2013 | 9351 | 0.010 |
Why?
|
Child, Preschool | 2 | 2016 | 42230 | 0.010 |
Why?
|
Safety | 1 | 2005 | 1150 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2016 | 3408 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15842 | 0.010 |
Why?
|
Brain | 1 | 2006 | 27112 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14666 | 0.010 |
Why?
|
Family | 1 | 2009 | 3194 | 0.010 |
Why?
|
Skin | 1 | 2012 | 4484 | 0.010 |
Why?
|
Risk | 1 | 2010 | 9610 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6534 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2013 | 18965 | 0.010 |
Why?
|
Prevalence | 1 | 2014 | 15732 | 0.010 |
Why?
|
Base Sequence | 1 | 2008 | 12441 | 0.010 |
Why?
|
Macrophages | 1 | 2011 | 5769 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13639 | 0.010 |
Why?
|
Aging | 1 | 2013 | 8708 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11076 | 0.010 |
Why?
|
Pregnancy | 1 | 2016 | 29874 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 12148 | 0.010 |
Why?
|
Hypertension | 1 | 2011 | 8540 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13380 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 23445 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2014 | 21012 | 0.000 |
Why?
|